ただし、追加料金で日本語のレポートが入手できる場合もある。
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Legionella Testing Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Application
6.1 Water Testing
6.1.1 Market Trends
6.1.2 Market Breakup by Type
6.1.2.1 Microbial Culture
6.1.2.2 DFA Stain
6.1.2.3 PCR
6.1.2.4 Others
6.1.3 Market Forecast
6.2 IVD Testing
6.2.1 Market Trends
6.2.2 Market Breakup by Type
6.2.2.1 Blood Culture
6.2.2.2 Urine Antigen Test
6.2.2.3 DFA Stain
6.2.2.4 PCR
6.2.2.5 Others
6.2.3 Market Forecast
7 Market Breakup by End User
7.1 Diagnostic Laboratories
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Hospital and Clinics
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Region
8.1 Europe
8.1.1 Italy
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Germany
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.1.3 France
8.1.3.1 Market Trends
8.1.3.2 Market Forecast
8.1.4 Spain
8.1.4.1 Market Trends
8.1.4.2 Market Forecast
8.1.5 United Kingdom
8.1.5.1 Market Trends
8.1.5.2 Market Forecast
8.1.6 Russia
8.1.6.1 Market Trends
8.1.6.2 Market Forecast
8.1.7 Others
8.1.7.1 Market Trends
8.1.7.2 Market Forecast
8.2 North America
8.2.1 United States
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Canada
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.3 Asia Pacific
8.3.1 China
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 Japan
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 Australia
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 South Korea
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Indonesia
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Singapore
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weakness
9.4 Opportunities
9.5 Threats
10 Value Chain Analysis
11 Porter’s Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Abbott Laboratories
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 Becton, Dickinson and Company
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.2.4 SWOT Analysis
13.3.3 BioMérieux SA
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.3.4 SWOT Analysis
13.3.4 Bio-Rad Laboratories Inc
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.4.4 SWOT Analysis
13.3.5 Eiken Chemical Co. Ltd
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.6 Quidel Corporation
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 Financials
13.3.6.4 SWOT Analysis
13.3.7 Takara Bio Inc.
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 inancials
13.3.8 Thermo Fisher Scientific Inc.
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.8.4 SWOT Analysis